Back to search

Senari Pharma Ltd

12329134

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Negative net worth (-10)

Details

71-75 SHELTON STREET, LONDON, WC2H 9JQ
Incorporated 22/11/2019

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Sanjeeva Dissanayake

director · Since 22/11/2019

CHIEF MEDICAL OFFICER

BRITISH · ENGLAND · Age 57

Persons with Significant Control

Dr Sanjeeva Dissanayake

50–75% shares
50–75% votes
Appoint directors

British · England · Age 57

143 Victoria Road, Queens Park, London, NW6 6TE

Notified 22/11/2019

Mr Zarni Win

25–50% shares
25–50% votes

British · England · Age 56

71-75, Shelton Street, London, WC2H 9JQ

Notified 04/09/2020

CompanyRankvs 2928+ SIC 72110 peers
33

Financial strength7th percentile among SIC peers · 2/25
Employees47th percentile among SIC peers · 7/15
LiquidityCurrent ratio 0.14× · 2/20
Longevity7 years trading (max 15) · 7/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength2/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees7/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity7/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/01/2025

Net Worth

-£177k

Balance sheet strength

Cash

£2k

Cash in the bank

Net Current Assets

-£177k

Working capital

Current Assets

£29k

Current Liabilities

£206k

Debtors

£27k

1avg. employees+1

Balance Sheet

Assets less current liabilities-£177k
Prepared with Sage Accounts Production Advanced 2024 - FRS102_2024

EstimatesDerived

YearCurrent RatioImplied Profit
20250.14-£57k
20240.18-£56k
20230.58-£59k
20220.97+£60k
20210.68

Derived from filed accounts. Not audited figures.